US 11078286
Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use
granted A61KA61K2039/505A61K2039/5156
Quick answer
US patent 11078286 (Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/505, A61K2039/5156, A61K39/0011, A61K39/39558